Search results

Back
1 - 10 of 391 Search results
 -  29 May 2018

 -  29 May 2018

Ipsen et le MD Anderson concluent un accord de partenariat pour le développement, du laboratoire au chevet du patient, d’un médicament contre le cancer

...

 -  29 May 2018

 -  29 May 2018

Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership

...

 -  25 February 2019

 -  25 February 2019

Ipsen annonce l’acquisition de Clementia Pharmaceuticals et renforce son portefeuille dans les Maladies Rares

Pièce jointe...

 -  13 March 2018

 -  13 March 2018

Ipsen appoints Ivana Magovčević-Liebisch Ph.D., J.D. and Régis Mulot to Executive Leadership Team

...

 -  21 February 2018

 -  21 February 2018

Arix Bioscience and Ipsen sign a strategic agreement to develop and commercialise innovative therapies

...

 -  21 February 2018

 -  21 February 2018

Arix Bioscience et Ipsen concluent un accord stratégique pour développer et commercialiser des thérapies innovantes

...

 -  13 March 2018

 -  13 March 2018

Ipsen nomme Ivana Magovčević-Liebisch, Ph.D., J.D., et Régis Mulot au sein de l’Executive Leadership Team

...

 -  29 January 2018

 -  29 January 2018

Dr Sotirios G. Stergiopoulos appointed as Ipsen Chief Medical Officer

...

 -  04 July 2018

 -  04 July 2018

Ipsen announces CELESTIAL phase 3 pivotal trial results in the New England Journal of Medicine

...

 -  29 January 2018

 -  29 January 2018

Le Docteur Sotirios G. Stergiopoulos est nommé Chief Medical Officer d’Ipsen

...

1 … 37 38 39 40